MAPK3 and cancer: When added to pancreatic cancer cells, exosomes from PSC or cancer-associated fibroblasts caused increased cancer cell aggressiveness, proliferation, migration, EMT, activation of ERK1/2, AKT, and expression of CXCL1/2, in part due to the actions of exosomal miR-21, -451a, and -5703.